Anthony Fauci says he will cooperate fully with possible House Republican investigation into Covid origins

Anthony Fauci says he will cooperate fully with possible House Republican investigation into Covid origins


Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, speaks about the coronavirus during the White House press briefing on Tuesday, November 22, 2022.

Tom Williams | Cq-roll Call, Inc. | Getty Images

CNBC Health & Science

Read CNBC’s latest global health coverage:

U.S. intelligence agencies under the Biden administration, in an assessment published in August 2021, were split about the most likely origin.

One agency had moderate confidence that the virus infected people after a lab incident, while four agencies assessed with low confidence that the virus had a natural origin, according to the assessment, which did not identify those agencies.

Earlier this year, Fauci announced that he will step down in December after leading the National Institute of Allergy and Infectious Diseases for nearly 40 years.

For decades, Fauci was respected as a public health servant on both sides of the political aisle.

But as the response to the pandemic became increasingly politicized under then-President Donald Trump, a Republican, Fauci became a lightning rod for many conservatives in Congress.

In addition to arguing with them over the origins of the virus, Fauci has also repeatedly clashed with Republicans in Congress over mask and vaccine policy.



Source

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to  billion
Health

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to $12 billion

A startup widely known as “ChatGPT for doctors” raised a new funding round that values the company at $12 billion. OpenEvidence, based in Miami, Florida, closed a $250 million financing, led by Thrive Capital and DST, the company told CNBC. The startup first raised outside capital in February, when it reeled in $75 million from […]

Read More
Another alliance of health care and AI signals why pharma stocks should be back in favor
Health

Another alliance of health care and AI signals why pharma stocks should be back in favor

Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with Microsoft’s AI-powered radiology platform to develop and launch imaging algorithms. These new tools, which can be used to […]

Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
Health

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US, on Friday, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0. Those are among the themes that dominated conversations last week as drugmakers […]

Read More